![]() | This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
Anti–PD-L1 Immunotherapy, MEK Inhibition Active in Metastatic CRC says "... previous studies have suggested that MEK inhibition could make a tumor more responsive to immunotherapy." - Could find some RS to add this. - Rod57 ( talk) 20:02, 5 July 2016 (UTC)
![]() | This article is rated Stub-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
|
Anti–PD-L1 Immunotherapy, MEK Inhibition Active in Metastatic CRC says "... previous studies have suggested that MEK inhibition could make a tumor more responsive to immunotherapy." - Could find some RS to add this. - Rod57 ( talk) 20:02, 5 July 2016 (UTC)